Synthesis and Biological Evaluation of 2,4,6-Trihydroxychalcone Derivatives as Novel Protein Tyrosine Phosphatase 1B Inhibitors

34Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A series of 2,4,6-trihydroxychalcone derivatives were synthesized and identified as reversible and competitive protein tyrosine phosphatase (PTP) 1B inhibitors with IC50 values in the micromolar range. Compound 4a had the greatest in vitro inhibition activity against PTP1B (IC50=0.27± 0.01μm) and the best selectivity (6.9-fold) for PTP1B relative to T-cell protein tyrosine phosphatases. The compounds identified herein provide a foundation on which to design specific inhibitors of PTP1B and other PTPs. © 2012 John Wiley & Sons A/S.

Cite

CITATION STYLE

APA

Sun, L. P., Gao, L. X., Ma, W. P., Nan, F. J., Li, J., & Piao, H. R. (2012). Synthesis and Biological Evaluation of 2,4,6-Trihydroxychalcone Derivatives as Novel Protein Tyrosine Phosphatase 1B Inhibitors. Chemical Biology and Drug Design, 80(4), 584–590. https://doi.org/10.1111/j.1747-0285.2012.01431.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free